33 related articles for article (PubMed ID: 20967317)
1. A G-quadruplex stabilizer induces M-phase cell cycle arrest.
Tsai YC; Qi H; Lin CP; Lin RK; Kerrigan JE; Rzuczek SG; LaVoie EJ; Rice JE; Pilch DS; Lyu YL; Liu LF
J Biol Chem; 2009 Aug; 284(34):22535-43. PubMed ID: 19531483
[TBL] [Abstract][Full Text] [Related]
2. Chemical targeting of G-quadruplexes in telomeres and beyond for molecular cancer therapeutics.
Seimiya H; Nagasawa K; Shin-Ya K
J Antibiot (Tokyo); 2021 Oct; 74(10):617-628. PubMed ID: 34285374
[TBL] [Abstract][Full Text] [Related]
3. Quadruplex Ligands in Cancer Therapy.
Sanchez-Martin V; Soriano M; Garcia-Salcedo JA
Cancers (Basel); 2021 Jun; 13(13):. PubMed ID: 34202648
[TBL] [Abstract][Full Text] [Related]
4. Identification of a gene cluster for telomestatin biosynthesis and heterologous expression using a specific promoter in a clean host.
Amagai K; Ikeda H; Hashimoto J; Kozone I; Izumikawa M; Kudo F; Eguchi T; Nakamura T; Osada H; Takahashi S; Shin-Ya K
Sci Rep; 2017 Jun; 7(1):3382. PubMed ID: 28611443
[TBL] [Abstract][Full Text] [Related]
5. Telomere and Telomerase Therapeutics in Cancer.
Xu Y; Goldkorn A
Genes (Basel); 2016 May; 7(6):. PubMed ID: 27240403
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the interaction between long telomeric DNA and macrocyclic hexaoxazole (6OTD) dimer of a G-quadruplex ligand.
Iida K; Majima S; Nakamura T; Seimiya H; Nagasawa K
Molecules; 2013 Apr; 18(4):4328-41. PubMed ID: 23584054
[TBL] [Abstract][Full Text] [Related]
7. Macrocyclic polyoxazoles as G-quadruplex ligands.
Iida K; Nagasawa K
Chem Rec; 2013 Dec; 13(6):539-48. PubMed ID: 24347328
[TBL] [Abstract][Full Text] [Related]
8. (S)-stereoisomer of telomestatin as a potent G-quadruplex binder and telomerase inhibitor.
Doi T; Shibata K; Yoshida M; Takagi M; Tera M; Nagasawa K; Shin-ya K; Takahashi T
Org Biomol Chem; 2011 Jan; 9(2):387-93. PubMed ID: 20967317
[TBL] [Abstract][Full Text] [Related]
9. The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures.
Kim MY; Gleason-Guzman M; Izbicka E; Nishioka D; Hurley LH
Cancer Res; 2003 Jun; 63(12):3247-56. PubMed ID: 12810655
[TBL] [Abstract][Full Text] [Related]
10. Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex.
Kim MY; Vankayalapati H; Shin-Ya K; Wierzba K; Hurley LH
J Am Chem Soc; 2002 Mar; 124(10):2098-9. PubMed ID: 11878947
[TBL] [Abstract][Full Text] [Related]
11. [Telomerase inhibitor, telomestatin, a specific mechanism to interact with telomere structure].
Shin-ya K
Nihon Rinsho; 2004 Jul; 62(7):1277-82. PubMed ID: 15283144
[TBL] [Abstract][Full Text] [Related]
12. Symmetrical bisbenzimidazoles with benzenediyl spacer: the role of the shape of the ligand on the stabilization and structural alterations in telomeric G-quadruplex DNA and telomerase inhibition.
Bhattacharya S; Chaudhuri P; Jain AK; Paul A
Bioconjug Chem; 2010 Jul; 21(7):1148-59. PubMed ID: 20536245
[TBL] [Abstract][Full Text] [Related]
13. Affinity and selectivity of G4 ligands measured by FRET.
De Cian A; Guittat L; Shin-ya K; Riou JF; Mergny JL
Nucleic Acids Symp Ser (Oxf); 2005; (49):235-6. PubMed ID: 17150720
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
